Should You Buy Utah Medical Products, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Utah Medical Products, Inc. (UTMD) scores a robust 8.2/10 on our 32-signal Quality of Company framework. At the current market price of $74.63 and a $238M market cap, our analysis maps this fundamental strength against 13 institutional-grade models to determine if a sufficient margin of safety exists.
The short answer: 5 of 11 CirclFi valuation models project upside for Utah Medical Products, Inc. (UTMD) at $74.63 — the model consensus leans bearish, with a Quality Score of 8.2/10 and Value-Trap risk of 6/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Utah Medical Products, Inc. (UTMD) in 2026?
What Is the Bull Case vs the Bear Case for Utah Medical Products, Inc. (UTMD)?
| Bull case — $109.28 target (+46.4%) | Bear case — $30.21 target (-59.5%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Utah Medical Products, Inc.'s quality score of 8.2/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $30.21 (-59.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the RCMH-DCF model targets a fair value of $109.28 (+46.4%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +105.9% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
How Does UTMD Compare to Its Medical Instruments & Supplies Peers?
Valuation data pages: PDEX · RGEN · NVST · EMBC · BDX · ATRC · STAA · KMTS · ALC · ISRG · RMD
Which Other Stocks Score Like UTMD on Quality?
Closest companies to UTMD’s Quality of Company score of 8.2/10, across all industries.
- ETD — Ethan Allen Interiors Inc. (QOC 8.2) · analysis
- SBFG — SB Financial Group, Inc. (QOC 8.2) · analysis
- CUBI — Customers Bancorp, Inc. (QOC 8.2) · analysis
- ARI — Apollo Commercial Real Estate Finance, Inc. (QOC 8.2) · analysis
- BCAL — California BanCorp (QOC 8.2) · analysis
- PGY — Pagaya Technologies Ltd. (QOC 8.2) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Instruments & Supplies Screens Does UTMD Appear In?
So Is Utah Medical Products, Inc. (UTMD) Worth Buying in 2026?
Utah Medical Products, Inc. at $74.63 is a genuine coin-flip in our framework. The 5–6 bull-bear split across 11 models, +105.9% model spread, and median fair value of $68.42 (-8.3% vs price) argue for a watchlist position rather than a high-conviction bet. Quality at 8.2/10 adds some comfort to the mix.
These are quantitative model outputs, not investment recommendations. Utah Medical Products, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About UTMD Stock?
Should I buy UTMD stock right now?
Based on CirclFi's multi-model analysis, 5 of 11 models see upside for UTMD at $74.63. The models are divided, which means the investment case depends heavily on your assumptions about Utah Medical Products, Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Utah Medical Products, Inc.?
Key risks include: wide model disagreement (262% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.
How does UTMD compare to its competitors?
Among Medical Instruments & Supplies peers, UTMD holds a Quality Score of 8.2/10. Comparable companies include PDEX (QOC 8.2), RGEN (QOC 8.0), NVST (QOC 8.3). The relative ranking helps investors identify whether UTMD offers better fundamental quality than alternatives in the same sector.
Is UTMD a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. UTMD's Quality Score of 8.2/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy UTMD at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $30.21 to $109.28. At $74.63, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for UTMD.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad